Avestar Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Sell
1,497
-732
-33% -$152K 0.02% 450
2026
Q1
$471K Buy
2,229
+547
+33% +$118K 0.03% 361
2025
Q4
$346K Buy
1,682
+30
+2% +$5.65K 0.02% 394
2025
Q3
$259K Buy
+1,652
New +$255K 0.02% 436
2024
Q4
Sell
-2,395
Closed -$265K 525
2024
Q3
$265K Buy
2,395
+330
+16% +$34.5K 0.03% 385
2024
Q2
$203K Buy
+2,065
New +$210K 0.02% 421
2019
Q3
Sell
-46
Closed -$1K 272
2019
Q2
$1K Sell
46
-1
-2% -$46 ﹤0.01% 732
2019
Q1
$1K Buy
47
+8
+21% +$401 ﹤0.01% 704
2018
Q4
$1K Buy
39
+33
+550% +$1.72K ﹤0.01% 692
2018
Q3
$0 Sell
6
-1
-14% -$51 ﹤0.01% 843
2018
Q2
$0 Sell
7
-55
-89% -$3.12K ﹤0.01% 884
2018
Q1
$4K Buy
62
+31
+100% +$2.13K ﹤0.01% 564
2017
Q4
$2K Buy
+31
New +$1.92K ﹤0.01% 618

Other funds holding CAH

Avestar Capital's CAH Position: Q2 2026 in Review

Avestar Capital reduced its Cardinal Health (CAH) stake by 33% in Q2 2026, selling an estimated $152K and leaving 1,497 shares worth $356K. The position accounts for 0.02% of the portfolio, ranked #450.

Avestar Capital first reported a position in CAH in Q4 2017 and has held it in 13 quarters since. The position peaked at $471K in Q1 2026. 617 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Avestar Capital held 1,497 shares of Cardinal Health worth $356K as of Q2 2026.
  • Avestar Capital sold 732 Cardinal Health shares in Q2 2026, an estimated $152K.
  • Cardinal Health made up 0.02% of Avestar Capital's portfolio in Q2 2026, its #450 holding.
  • Avestar Capital first reported a position in Cardinal Health in Q4 2017 and has held it in 13 quarters since.
  • Avestar Capital's Cardinal Health position peaked at $471K in Q1 2026.
  • 617 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.